A Pilot Study on AI-Based Voice Analysis for Monitoring Patients Hospitalized With Acute Decompensated Heart Failure
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- Noah Labs
- Enrollment
- 70
- Locations
- 2
- Primary Endpoint
- Change in vocal characteristics from admission to discharge and their correlation with heart failure severity markers.
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinically diagnosed with Acutely Decompensated Heart Failure.
- •At least 18 years of age.
- •Exclusion criteria:
- •Disabling mental diseases (e.g., Alzheimer's disease)
- •Clinically diagnosed chronic obstructive pulmonary disease (COPD)
- •Treatment in ICU or IMU
- •Dialysis treatment
- •Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.)
- •Neurodegenerative diseases
- •Pregnancy
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Change in vocal characteristics from admission to discharge and their correlation with heart failure severity markers.
Time Frame: Hospital stay
The primary endpoint is the change in vocal characteristics from admission to discharge, and its correlation with clinical markers of heart failure severity, such as weight change from admission to discharge, NTpro-BNP levels, ECG-parameters, and left ventricular ejection fraction (LVEF).